Agenus Inc (NASDAQ: AGEN)’s stock price has plunge by 10.59relation to previous closing price of 3.54. Nevertheless, the company has seen a 9.66% surge in its stock price over the last five trading sessions. businesswire.com reported 2025-01-29 that LEXINGTON, Mass.–(BUSINESS WIRE)–Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced publication in the Journal of Clinical Oncology showcasing data from its study of botensilimab (BOT) in combination with balstilimab (BAL) in patients with relapsed/refractory (R/R) metastatic sarcomas. These findings further reinforce the consistency of the BOT/BAL combination, which has already shown activity and a favorable safety profile across both multiple “warm and cold” tumor type.
Is It Worth Investing in Agenus Inc (NASDAQ: AGEN) Right Now?
The 36-month beta value for AGEN is at 1.30. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for AGEN is 22.36M, and currently, shorts hold a 13.14% of that float. The average trading volume for AGEN on January 31, 2025 was 534.05K shares.
AGEN’s Market Performance
The stock of Agenus Inc (AGEN) has seen a 9.66% increase in the past week, with a 45.54% rise in the past month, and a -12.22% fall in the past quarter. The volatility ratio for the week is 7.95%, and the volatility levels for the past 30 days are at 9.13% for AGEN. The simple moving average for the last 20 days is 13.68% for AGEN stock, with a simple moving average of -45.69% for the last 200 days.
Analysts’ Opinion of AGEN
Many brokerage firms have already submitted their reports for AGEN stocks, with Robert W. Baird repeating the rating for AGEN by listing it as a “Neutral.” The predicted price for AGEN in the upcoming period, according to Robert W. Baird is $8 based on the research report published on July 19, 2024 of the previous year 2024.
H.C. Wainwright gave a rating of “Neutral” to AGEN, setting the target price at $9 in the report published on July 18th of the previous year.
AGEN Trading at 21.60% from the 50-Day Moving Average
After a stumble in the market that brought AGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.11% of loss for the given period.
Volatility was left at 9.13%, however, over the last 30 days, the volatility rate increased by 7.95%, as shares surge +45.09% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +46.15% upper at present.
During the last 5 trading sessions, AGEN rose by +11.36%, which changed the moving average for the period of 200-days by -38.84% in comparison to the 20-day moving average, which settled at $3.45. In addition, Agenus Inc saw 42.88% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AGEN starting from ARMEN GARO H, who purchase 500,000 shares at the price of $0.65 back on Feb 15 ’24. After this action, ARMEN GARO H now owns 625,969 shares of Agenus Inc, valued at $324,050 using the latest closing price.
Stock Fundamentals for AGEN
Current profitability levels for the company are sitting at:
- -0.62 for the present operating margin
- 0.69 for the gross margin
The net margin for Agenus Inc stands at -1.42. The total capital return value is set at 3.08.
Based on Agenus Inc (AGEN), the company’s capital structure generated -1.72 points at debt to capital in total, while cash flow to debt ratio is standing at -3.08. The debt to equity ratio resting at -0.63. The interest coverage ratio of the stock is -0.7.
Currently, EBITDA for the company is -145.92 million with net debt to EBITDA at -0.13. When we switch over and look at the enterprise to sales, we see a ratio of 0.62. The receivables turnover for the company is 775.01for trailing twelve months and the total asset turnover is 0.67. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.19.
Conclusion
In conclusion, Agenus Inc (AGEN) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
